Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Mohammed, Yousuf H ^a,b   Yamada, Miko ^a   Lin, Lynlee L ^a   Grice, Jeffrey E ^a   Roberts, Michael S ^a   Raphael, Anthony P ^a   Benson, Heather A E ^b   Prow, Tarl W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; MELANOSTATIN; PALMITOYL LYSYLTHREONYLTHREONYLLYSYLSERINE; RIGIN; UNCLASSIFIED DRUG; OLIGOPEPTIDE; PALMITOYL-LYSYL-THREONYL-THREONYL-LYSYL-SERINE; PEPTIDE;

ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DERMIS; DRUG DELIVERY SYSTEM; EPIDERMIS; FLUORESCENCE IMAGING; HUMAN; HUMAN TISSUE; LIGHT INTENSITY; MICRONEEDLE; MOLECULAR WEIGHT; SKIN PENETRATION; SKIN STRUCTURE; SKINFOLD THICKNESS; TISSUE DISTRIBUTION; ABDOMINOPLASTY; CONFOCAL MICROSCOPY; ESTHETIC SURGERY; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; INTRADERMAL DRUG ADMINISTRATION; MICROINJECTION; PLASTIC SURGERY; PROCEDURES; SKIN;

ABDOMINOPLASTY; ADMINISTRATION, CUTANEOUS; COSMETIC TECHNIQUES; DRUG DELIVERY SYSTEMS; HUMANS; MICROINJECTIONS; MICROSCOPY, CONFOCAL; MSH RELEASE-INHIBITING HORMONE; OLIGOPEPTIDES; OPTICAL IMAGING; PEPTIDES; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; SURGERY, PLASTIC;

EID: 84904498025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101956     Document Type: Article

References (14)

1. Zhang X, Hu X, Hou A, Wang H (2009) Inhibitory effect of 2,4,2′,4′-tetrahydroxy-3-(3-methyl-2-butenyl)-chalcone on tyrosinase activity and melanin biosynthesis. Biological & pharmaceutical bulletin 32: 86-90.
2. Donald JE, Shakhnovich EI (2009) SDR: a database of predicted specificity-determining residues in proteins. Nucleic acids research 37: D191-194.
3. Lintner K (2000) Use of peptides as cosmetics or pharmaceuticals for the regulation of immunological dysfunctions and in cutaneous inflammation. In: Application WP, editor. France: SEDERMA S.A.
4. Zhang L, Falla TJ (2009) Cosmeceuticals and peptides. Clinics in dermatology 27: 485-494.
5. Martanto W, Moore JS, Couse T, Prausnitz MR (2006) Mechanism of fluid infusion during microneedle insertion and retraction. Journal of controlled release: official journal of the Controlled Release Society 112: 357-361.
6. Bal SM, Kruithof AC, Zwier R, Dietz E, Bouwstra JA, et al. (2010) Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo. Journal of controlled release: official journal of the Controlled Release Society 147: 218-224.
7. Banks SL, Pinninti RR, Gill HS, Paudel KS, Crooks PA, et al. (2010) Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs. Journal of pharmaceutical sciences 99: 3072-3080.
8. Banks SL, Paudel KS, Brogden NK, Loftin CD, Stinchcomb AL (2011) Diclofenac enables prolonged delivery of naltrexone through microneedletreated skin. Pharmaceutical research 28: 1211-1219.
9. Prausnitz MR (2006) A peptide chaperone for transdermal drug delivery. Nature biotechnology 24: 416-417.
10. Gill HS, Prausnitz MR (2008) Pocketed Microneedles for Drug Delivery to the Skin. The Journal of physics and chemistry of solids 69: 1537-1541.
11. Sauermann K, Gambichler T, Wilmert M, Rotterdam S, Stucker M, et al. (2002) Investigation of basal cell carcinoma [correction of carcionoma] by confocal laser scanning microscopy in vivo. Skin research and technology: official journal of International Society for Bioengineering and the Skin 8: 141-147.
12. Kim YC, Park JH, Prausnitz MR (2012) Microneedles for drug and vaccine delivery. Advanced drug delivery reviews 64: 1547-1568.
13. Benson HA, Namjoshi S (2008) Proteins and peptides: strategies for delivery to and across the skin. Journal of pharmaceutical sciences 97: 3591-3610.
14. Sachdeva V, Zhou Y, Banga AK (2013) In vivo transdermal delivery of leuprolide using microneedles and iontophoresis. Current pharmaceutical biotechnology 14: 180-193.